Safety monitoring of bivalent, quadrivalent, and 9-valent human papillomavirus vaccination in Japan: The vaccine effectiveness, networking, and universal safety (VENUS) study.

Ishiguro C, Morita H, Mimura W, Tsuzuki S, Hirashima-Terada J, Takeuchi Y, Oda F, Maeda M, Fukuda H

Open source

DOI
10.1080/21645515.2026.2688606
Published
2026 Dec
Container
Human vaccines & immunotherapeutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/21645515.2026.2688606,
  title = {Safety monitoring of bivalent, quadrivalent, and 9-valent human papillomavirus vaccination in Japan: The vaccine effectiveness, networking, and universal safety (VENUS) study.},
  author = {Ishiguro C and Morita H and Mimura W and Tsuzuki S and Hirashima-Terada J and Takeuchi Y and Oda F and Maeda M and Fukuda H},
  year = {2026},
  journal = {Human vaccines \& immunotherapeutics},
  doi = {10.1080/21645515.2026.2688606},
  url = {https://doi.org/10.1080/21645515.2026.2688606}
}

RIS

TY  - JOUR
TI  - Safety monitoring of bivalent, quadrivalent, and 9-valent human papillomavirus vaccination in Japan: The vaccine effectiveness, networking, and universal safety (VENUS) study.
AU  - Ishiguro C
AU  - Morita H
AU  - Mimura W
AU  - Tsuzuki S
AU  - Hirashima-Terada J
AU  - Takeuchi Y
AU  - Oda F
AU  - Maeda M
AU  - Fukuda H
PY  - 2026
JO  - Human vaccines & immunotherapeutics
DO  - 10.1080/21645515.2026.2688606
UR  - https://doi.org/10.1080/21645515.2026.2688606
ER  - 

APA

C, I., H, M., W, M., S, T., J, H., Y, T., F, O., M, M., & H, F. (2026). Safety monitoring of bivalent, quadrivalent, and 9-valent human papillomavirus vaccination in Japan: The vaccine effectiveness, networking, and universal safety (VENUS) study.. Human vaccines & immunotherapeutics. https://doi.org/10.1080/21645515.2026.2688606

Source records